GlassScriptPhysician profile
Yizhou Ernst
NPI 1174942569
$7,338.44
in general payments reported to CMS, 2019-2025
17 companies · $745 in 2025
The $745 reported for 2025 was more than what 81% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.88 · 2021: $5,042 · 2022: $274 · 2023: $1,110 · 2024: $154 · 2025: $745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,419 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Education: $90.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,418.92 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Education | $90.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,690.50 | 2021-2023 | Da Vinci Sp, Da Vinci Surgical System |
| Hologic Sales and Service, LLC | $303.05 | 2022-2023 | Coolseal Generator, Acessa Provu System, Myosure Tissue Removal Device |
| Astellas Pharma US INC | $289.26 | 2023-2025 | Veozah |
| Abbvie INC. | $244.60 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $218.63 | 2023-2025 | Rexulti, Abilify Asimtufii |
| Galderma Laboratories, L.P. | $121.08 | 2023 | |
| Sumitomo Pharma America, INC. | $89.72 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $60.87 | 2023-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $58.48 | 2025 | Lumryz |
| Merck Sharp & Dohme LLC | $55.38 | 2019-2023 | Gardasil 9 |
| Mayne Pharma Commercial LLC | $45.90 | 2023-2025 | |
| Inspire Medical Systems, INC. | $39.42 | 2025 | Inspire |
| Medtronic, INC. | $38.93 | 2023 | Nuro |
| Pfizer INC. | $23.87 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.62 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $18.96 | 2025 | Zepbound, Mounjaro |
| Sage Therapeutics, LLC | $18.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yizhou Ernst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.